Cargando…
APOBEC-mediated mutagenesis is a favorable predictor of prognosis and immunotherapy for bladder cancer patients: evidence from pan-cancer analysis and multiple databases
Background: The APOBEC (apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like) family-mediated mutagenesis is widespread in human cancers. However, our knowledge of the biological feature and clinical relevance of APOBECs and APOBEC mutagenesis in cancers remains limited. Methods: In this...
Autores principales: | Shi, Run, Wang, Xin, Wu, Yang, Xu, Bin, Zhao, Tianyu, Trapp, Christian, Wang, Xuanbin, Unger, Kristian, Zhou, Cheng, Lu, Shun, Buchner, Alexander, Schulz, Gerald Bastian, Cao, Fengjun, Belka, Claus, Su, Chuan, Li, Minglun, Shu, Yongqian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9169361/ https://www.ncbi.nlm.nih.gov/pubmed/35673559 http://dx.doi.org/10.7150/thno.73235 |
Ejemplares similares
-
Identification and validation of hypoxia-derived gene signatures to predict clinical outcomes and therapeutic responses in stage I lung adenocarcinoma patients
por: Shi, Run, et al.
Publicado: (2021) -
A Novel Gene Signature-Based Model Predicts Biochemical Recurrence-Free Survival in Prostate Cancer Patients after Radical Prostatectomy
por: Shi, Run, et al.
Publicado: (2019) -
Elective nodal radiotherapy with a gapless radiation field junction for oligorecurrent prostate cancer after previous radiotherapy
por: Li, Minglun, et al.
Publicado: (2022) -
Establishment and Validation of an Individualized Cell Cycle Process-Related Gene Signature to Predict Cancer-Specific Survival in Patients with Bladder Cancer
por: Shi, Run, et al.
Publicado: (2020) -
Radiotherapy of oligometastatic prostate cancer: a systematic review
por: Rogowski, Paul, et al.
Publicado: (2021)